Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.China |
First Approval Date11 Oct 2004 |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.China |
First Approval Date30 Nov 2002 |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.China |
First Approval Date01 Jan 1996 |
100 Clinical Results associated with Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.
0 Patents (Medical) associated with Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.
100 Deals associated with Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.
100 Translational Medicine associated with Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.